A retrospective comparative study of two concentrations of intralesional triamcinolone acetonide in the treatment of patchy alopecia areata on the scalp
Clinical, Cosmetic and Investigational Dermatology Nov 05, 2020
Muhaidat JM, Al-Qarqaz F, Khader Y, et al. - In this study, the effectiveness and safety of two commonly used concentrations of intralesional triamcinolone acetonide (ILT) (5 mg/mL vs 10 mg/mL) were compared in the treatment of patchy alopecia areata (AA) on the scalp. Researchers performed a retrospective comparative study including a total of 85 individuals diagnosed with patchy AA on the scalp, who were treated with monthly injections of ILT. Individuals were categorized into Group 1 that received 5 mg/mL and Group 2 that received 10 mg/mL. This study’s findings demonstrate that intralesional injection of triamcinolone acetonide 5 mg/mL is equally effective and safe in comparison with 10 mg/mL in the treatment of patchy alopecia areata.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries